The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
127644171 12764417 1 I 20160704 20160914 20160920 20160920 EXP US-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2016-BI-60429BP BOEHRINGER INGELHEIM 0.00 E F Y 108.80000 KG 20160920 OT US US

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
127644171 12764417 1 PS SPIRIVA TIOTROPIUM BROMIDE MONOHYDRATE 1 Unknown 21936 PRESSURISED INHALATION QD
127644171 12764417 2 SS EYLEA AFLIBERCEPT 1 Intraocular FORMULATION: INJECTION, STRENGTH: 2MG (PRESUMED) 0 /month
127644171 12764417 3 SS EYLEA AFLIBERCEPT 1 Intraocular STRENGTH: 2MG (PRESUMED), SITE: RIGHT EYE (OD) 0 /month
127644171 12764417 4 SS EYLEA AFLIBERCEPT 1 Intraocular STRENGTH: 2MG (PRESUMED), SITE: RIGHT EYE (OD) 0 /month
127644171 12764417 5 SS GABAPENTIN. GABAPENTIN 1 Unknown Y 0 QD
127644171 12764417 6 SS GABAPENTIN. GABAPENTIN 1 Unknown Y 0 QD
127644171 12764417 7 SS AZELASTINE HCL AZELASTINE HYDROCHLORIDE 1 Nasal 0
127644171 12764417 8 SS FLONASE FLUTICASONE PROPIONATE 1 Nasal 0
127644171 12764417 9 SS MONTELUKAST SODIUM. MONTELUKAST SODIUM 1 Unknown 10 MG 0 10 MG QD
127644171 12764417 10 SS SYMBICORT BUDESONIDEFORMOTEROL FUMARATE DIHYDRATE 1 Respiratory (inhalation) 4 ANZ 0 PRESSURISED INHALATION BID
127644171 12764417 11 SS ZYRTEC CETIRIZINE HYDROCHLORIDE 1 Unknown 10 MG 0 10 MG QD
127644171 12764417 12 SS ALBUTEROL. ALBUTEROL 1 Unknown 0 180 UG
127644171 12764417 13 C LOSARTAN/HCTZ HYDROCHLOROTHIAZIDELOSARTAN 1 Unknown 0
127644171 12764417 14 C ZETIA EZETIMIBE 1 Unknown 0

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
127644171 12764417 1 Product used for unknown indication
127644171 12764417 2 Neovascular age-related macular degeneration
127644171 12764417 5 Spinal column stenosis
127644171 12764417 7 Product used for unknown indication
127644171 12764417 8 Product used for unknown indication
127644171 12764417 9 Product used for unknown indication
127644171 12764417 10 Product used for unknown indication
127644171 12764417 11 Product used for unknown indication
127644171 12764417 12 Product used for unknown indication
127644171 12764417 13 Product used for unknown indication
127644171 12764417 14 Product used for unknown indication

Outcome of event

Event ID CASEID OUTC COD
127644171 12764417 OT

Reactions reported

Event ID CASEID DRUG REC ACT PT
127644171 12764417 Asthma
127644171 12764417 Drug ineffective
127644171 12764417 Eosinophil count increased
127644171 12764417 Pulmonary function test decreased
127644171 12764417 Transient ischaemic attack

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

Event ID CASEID DSG DRUG SEQ START DT END DT DUR DUR COD
127644171 12764417 2 20160524 0
127644171 12764417 3 20160621 20160621 0
127644171 12764417 4 20160719 20160719 0
127644171 12764417 5 201601 201602 0
127644171 12764417 6 20160703 0